RESUMEN
We hypothesized that pulmonary granulocyte-macrophage colony-stimulating factor (GM-CSF) is critically involved in determining the functional capabilities of alveolar macrophages (AM) for host defense. To test this hypothesis, cells were collected by lung lavage from GM-CSF mutant mice [GM(-/-)] and C57BL/6 wild-type mice. GM(-/-) mice yielded almost 4-fold more AM than wild-type mice. The percentage of cells positive for the beta(2)-integrins CD11a and CD11c was reduced significantly in GM(-/-) AM compared with wild-type cells, whereas expression of CD11b was similar in the two groups. The phagocytic activity of GM(-/-) AM for FITC-labeled microspheres was impaired significantly compared with that of wild-type AM both in vitro and in vivo (after intratracheal inoculation with FITC-labeled beads). Stimulated secretion of tumor necrosis factor-alpha (TNF-alpha) and leukotrienes by AM from the GM(-/-) mice was greatly reduced compared with wild-type AM, whereas secretion of monocyte chemoattractant protein-1 was increased. Transgenic expression of GM-CSF exclusively in the lungs of GM(-/-) mice resulted in AM with normal or supranormal expression of CD11a and CD11c, phagocytic activity, and TNF-alpha secretion. Thus, in the absence of GM-CSF, AM functional capabilities for host defense were significantly impaired but were restored by lung-specific expression of GM-CSF.
Asunto(s)
Factor Estimulante de Colonias de Granulocitos y Macrófagos/fisiología , Macrófagos Alveolares/fisiología , Animales , Lavado Broncoalveolar , Antígenos CD18/metabolismo , Adhesión Celular , Quimiocina CCL2/metabolismo , Citometría de Flujo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/deficiencia , Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Leucotrienos/metabolismo , Macrófagos Alveolares/citología , Macrófagos Alveolares/inmunología , Ratones , Ratones Transgénicos , Microesferas , Fagocitosis , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
We have previously shown that the ability of overnight pretreatment with lipopolysaccharide (LPS) to suppress alveolar macrophage (AM) leukotrienes (LT) synthesis is explained by induction of nitric oxide (NO), and reactive oxygen intermediates (ROI). More recently we have demonstrated that the generation of peroxynitrite (ONOO-) from the combination of NO and ROI directly nitrotyrosinates the 5-lipoxygenase (5-LO) enzyme and reduces cell-free and intact AM 5-LO metabolism. This effect of ONOO- was associated with nitrotyrosination of the 5-LO enzyme in intact cells and after treatment of recombinant enzyme. We postulated that LPS treatment of cells resulted in activation of 5-LO with the generation of ROI, which in turn led to autoinactivation of the enzyme. In an effort to suppress ROI generated from activation of 5-LO we examined the effect of a direct 5-LO inhibitor on LPS-induced suppression of LT synthesis. Coincubation with the reversible 5-LO inhibitor zileuton during the LPS pretreatment of intact cells dose dependently blocked the inhibition of 5-LO metabolism by LPS. The effect of zileuton on LPS-induced suppression of LT synthesis was similar to that of N-monomethyl-L-arginine. Zileuton had no effect on inducible nitric-oxide synthase induction. Interestingly, zileuton blocked ONOO--induced nitrotyrosination of recombinant 5-LO in a cell-free system as well as of native enzyme in intact cells. Moreover, zileuton blocked the nitrotyrosination of other proteins. We conclude that the suppression of 5-LO activity occurring with LPS treatment can be blocked by zileuton. The mechanism by which zileuton is effective is in part explained by blocking nitrotyrosination of 5-LO.
Asunto(s)
Hidroxiurea/farmacología , Inhibidores de la Lipooxigenasa/farmacología , Nitratos/farmacología , Proteínas/metabolismo , Tirosina/análogos & derivados , Tirosina/metabolismo , Animales , Western Blotting , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Femenino , Hidroxiurea/análogos & derivados , Leucotrieno B4/farmacología , Pruebas de Precipitina , Ratas , Ratas Wistar , omega-N-Metilarginina/farmacologíaRESUMEN
Production of the C-X-C chemokines interleukin-8 (IL-8) and growth-regulated oncogene alpha (GRO-alpha) in macrophages is stimulated by exposure to human immunodeficiency virus type 1 (HIV-1). We have demonstrated previously that GRO-alpha then stimulates HIV-1 replication in both T lymphocytes and macrophages. Here we demonstrate that IL-8 also stimulates HIV-1 replication in macrophages and T lymphocytes. We further show that increased levels of IL-8 are present in the lymphoid tissue of patients with AIDS. In addition, we demonstrate that compounds which inhibit the actions of IL-8 and GRO-alpha via their receptors, CXCR1 and CXCR2, also inhibit HIV-1 replication in both T lymphocytes and macrophages, indicating potential therapeutic uses for these compounds in HIV-1 infection and AIDS.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/virología , Quimiocinas CXC , VIH-1/efectos de los fármacos , Péptidos y Proteínas de Señalización Intercelular , Interleucina-8/farmacología , Macrófagos/virología , Linfocitos T/virología , Síndrome de Inmunodeficiencia Adquirida/inmunología , Anticuerpos/inmunología , Quimiocina CXCL1 , Factores Quimiotácticos/antagonistas & inhibidores , Factores Quimiotácticos/farmacología , Sustancias de Crecimiento/farmacología , VIH-1/fisiología , Humanos , Interleucina-8/antagonistas & inhibidores , Interleucina-8/inmunología , Interleucina-8/metabolismo , Tejido Linfoide/inmunología , Tejido Linfoide/metabolismo , Monocitos , Compuestos de Fenilurea/farmacología , Receptores de Interleucina-8A/inmunología , Receptores de Interleucina-8B/inmunología , Replicación Viral/efectos de los fármacosRESUMEN
We examined the early effects of infection by CCR5-using (R5 human immunodeficiency virus [HIV]) and CXCR4-using (X4 HIV) strains of HIV type 1 (HIV-1) on chemokine production by primary human monocyte-derived macrophages (MDM). While R5 HIV, but not X4 HIV, replicated in MDM, we found that the production of the C-X-C chemokine growth-regulated oncogene alpha (GRO-alpha) was markedly stimulated by X4 HIV and, to a much lesser extent, by R5 HIV. HIV-1 gp120 engagement of CXCR4 initiated the stimulation of GRO-alpha production, an effect blocked by antibodies to CXCR4. GRO-alpha then fed back and stimulated HIV-1 replication in both MDM and lymphocytes, and antibodies that neutralize GRO-alpha or CXCR2 (the receptor for GRO-alpha) markedly reduced viral replication in MDM and peripheral blood mononuclear cells. Therefore, activation of MDM by HIV-1 gp120 engagement of CXCR4 initiates an autocrine-paracrine loop that may be important in disease progression after the emergence of X4 HIV.
Asunto(s)
Quimiocinas CXC , Factores Quimiotácticos/biosíntesis , Sustancias de Crecimiento/biosíntesis , VIH-1/fisiología , Péptidos y Proteínas de Señalización Intercelular , Macrófagos/virología , Linfocitos T/virología , Replicación Viral , Quimiocina CXCL1 , Proteína gp120 de Envoltorio del VIH/fisiología , Humanos , Receptores CXCR4/fisiología , Receptores de Interleucina-8B/fisiologíaRESUMEN
12/15-Lipoxygenase (LOX) activity is elevated in vascular diseases associated with impaired nitric oxide (( small middle dot)NO) bioactivity, such as hypertension and atherosclerosis. In this study, primary porcine monocytes expressing 12/15-LOX, rat A10 smooth muscle cells transfected with murine 12/15-LOX, and purified porcine 12/15-LOX all consumed *NO in the presence of lipid substrate. Suppression of LOX diene conjugation by *NO was also found, although the lipid product profile was unchanged. *NO consumption by porcine monocytes was inhibited by the LOX inhibitor, eicosatetraynoic acid. Rates of arachidonate (AA)- or linoleate (LA)-dependent *NO depletion by porcine monocytes (2.68 +/- 0.03 nmol x min(-1) x 10(6) cells(-1) and 1.5 +/- 0.25 nmol x min(-1) x 10(6) cells(-1), respectively) were several-fold greater than rates of *NO generation by cytokine-activated macrophages (0.1-0.2 nmol x min(-1) x 10(6) cells(-1)) and LA-dependent *NO consumption by primary porcine monocytes inhibited *NO activation of soluble guanylate cyclase. These data indicate that catalytic *NO consumption by 12/15-LOX modulates monocyte *NO signaling and suggest that LOXs may contribute to vascular dysfunction not only by the bioactivity of their lipid products, but also by serving as catalytic sinks for *NO in the vasculature.
Asunto(s)
Araquidonato 12-Lipooxigenasa/metabolismo , Guanilato Ciclasa/metabolismo , Monocitos/metabolismo , Óxido Nítrico/metabolismo , Animales , Catálisis , Técnicas de Cultivo de Célula , Activación Enzimática , Músculo Liso , Ratas , Especificidad por Sustrato , Porcinos , TransfecciónRESUMEN
Enhanced prostaglandin production during fungal infection could be an important factor in promoting fungal colonization and chronic infection. Host cells are one source of prostaglandins; however, another potential source of prostaglandins is the fungal pathogen itself. Our objective was to determine if the pathogenic yeasts Cryptococcus neoformans and Candida albicans produce prostaglandins and, if so, to begin to define the role of these bioactive lipids in yeast biology and disease pathogenesis. C. neoformans and C. albicans both secreted prostaglandins de novo or via conversion of exogenous arachidonic acid. Treatment with cyclooxygenase inhibitors dramatically reduced the viability of the yeast and the production of prostaglandins, suggesting that an essential cyclooxygenase like enzyme may be responsible for fungal prostaglandin production. A PGE series lipid was purified from both C. albicans and C. neoformans and was biologically active on both fungal and mammalian cells. Fungal PGE(x) and synthetic PGE(2) enhanced the yeast-to-hypha transition in C. albicans. Furthermore, in mammalian cells, fungal PGE(x) down-modulated chemokine production, tumor necrosis factor alpha production, and splenocyte proliferation while up-regulating interleukin 10 production. These are all activities previously documented for mammalian PGE(2). Thus, eicosanoids are produced by pathogenic fungi, are critical for growth of the fungi, and can modulate host immune functions. The discovery that pathogenic fungi produce and respond to immunomodulatory eicosanoids reveals a virulence mechanism that has potentially great implications for understanding the mechanisms of chronic fungal infection, immune deviation, and fungi as disease cofactors.
Asunto(s)
Candida albicans/metabolismo , Cryptococcus neoformans/metabolismo , Prostaglandinas/biosíntesis , Animales , Candida albicans/patogenicidad , Cryptococcus neoformans/patogenicidad , Ensayo de Inmunoadsorción Enzimática , Indometacina/farmacología , Activación de Linfocitos/efectos de los fármacos , Ratones , Ratones Endogámicos CBA , Prostaglandinas/farmacología , Factor de Necrosis Tumoral alfa/biosíntesis , VirulenciaRESUMEN
The in vitro glucuronidation of a range of structurally diverse chemicals has been studied in hepatic and renal microsomes from human donors and the beagle dog. These studies were undertaken to improve on the limited knowledge of glucuronidation by the dog and to assess its suitability as a model species for pharmacokinetic studies. In general, the compounds studied were glucuronidated severalfold more rapidly (based on intrinsic clearance estimates) by DLM than by HLM. Intrinsic clearance values for human UGT1A1 and UGT2B7 substrates were an order of magnitude higher in DLM than in HLM (e.g., gemfibrozil: 31 microl/min/mg versus 3.0 microl/min/mg; ketoprofen: 2.4 microl/min/mg versus 0.2 microl/min/mg). There were also drug-specific differences. HLM readily glucuronidated propofol (2.4 microl/min/mg) whereas DLM appeared unable to glucuronidate this drug directly. Regioselective differences in morphine glucuronidation were also apparent. Human kidney microsomes catalyzed the glucuronidation of many xenobiotics, although glucuronidation of the endobiotic bilirubin was not detectable in this tissue. In direct contrast, dog kidney microsomes glucuronidated bilirubin only (no glucuronidation of all other xenobiotics was detected). These preliminary studies indicated significant differences in the glucuronidation of xenobiotics by microsomes from the livers and kidneys of human and dog and should be confirmed using a larger panel of tissues from individual dogs. Early knowledge of the relative rates of in vitro glucuronidation, the UGTs responsible for drug glucuronidation, and their tissue distribution in different species could assist the design and analysis of preclinical pharmacokinetic and safety evaluation studies.
Asunto(s)
Glucurónidos/biosíntesis , Cetoprofeno/análogos & derivados , Riñón/metabolismo , Microsomas Hepáticos/metabolismo , Adulto , Androstano-3,17-diol/análogos & derivados , Androstano-3,17-diol/biosíntesis , Androstano-3,17-diol/metabolismo , Androstano-3,17-diol/farmacocinética , Animales , Perros , Femenino , Furosemida/análogos & derivados , Furosemida/metabolismo , Furosemida/farmacocinética , Gemfibrozilo/metabolismo , Gemfibrozilo/farmacocinética , Glucuronidasa/metabolismo , Humanos , Cetoprofeno/metabolismo , Cetoprofeno/farmacocinética , Riñón/enzimología , Cinética , Masculino , Microsomas/enzimología , Microsomas/metabolismo , Microsomas Hepáticos/enzimología , Persona de Mediana Edad , Modelos Animales , Propofol/metabolismo , Propofol/farmacocinética , Especificidad de la EspecieRESUMEN
Nitric oxide (NO) is a major free radical modulator of smooth muscle tone, which under basal conditions acts to preserve vascular homeostasis through its anti-inflammatory properties. The biochemistry of NO, in particular, its rapid conversion in vivo into secondary reactive nitrogen species (RNS), its chemical nature as a free radical and its high diffusibility and hydrophobicity dictate that this species will interact with numerous biomolecules and enzymes. In this review, we consider the interactions of a number of enzymes found in the vasculature with NO and NO-derived RNS. All these enzymes are either homeostatic or promote the development of atherosclerosis and hypertension. Therefore their interactions with NO and NO-derived RNS will be of central importance in the initiation and progression of vascular disease. In some examples, (e.g. lipoxygenase, LOX), such interactions provide catalytic 'sinks' for NO, but for others, in particular peroxidases and prostaglandin H synthase (PGHS), reactions with NO may be detrimental. Nitric oxide and NO-derived RNS directly modulate the activity of vascular peroxidases and LOXs through a combination of effects, including transcriptional regulation, altering substrate availability, and direct reaction with enzyme turnover intermediates. Therefore, these interactions will have two major consequences: (i) depletion of NO levels available to cause vasorelaxation and prevent leukocyte/platelet adhesion and (ii) modulation of activity of the target enzymes, thereby altering the generation of bioactive signaling molecules involved in maintenance of vascular homeostasis, including prostaglandins and leukotrienes.
Asunto(s)
Lipooxigenasa/metabolismo , Óxido Nítrico/metabolismo , Peroxidasas/metabolismo , Especies de Nitrógeno Reactivo/metabolismo , Animales , Vasos Sanguíneos/metabolismo , Glutatión Peroxidasa/metabolismo , Homeostasis , Humanos , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo III , Prostaglandina-Endoperóxido Sintasas/metabolismo , Enfermedades Vasculares/etiología , Enfermedades Vasculares/metabolismoRESUMEN
Several drug-metabolizing enzymes including bilirubin UDP-glucuronosyltransferase (UGT1A1) are influenced by long-term ethanol consumption. In the present study, the activity and expression of UGT1A1 were investigated in livers of ethanol-treated rats. Animals were treated daily for 15 days with ethanol or isocaloric amount of glucose solution by gastric intubation. Microsomes and total RNA were prepared from the liver of rats and analyzed by Western blot and Northern hybridization using UGT1A1 specific antibody and cDNA probe. Microsomal bilirubin UGT activity was also measured. The elevation of UGT1A1 mRNA was observed in the liver of ethanol consumer animals with the simultaneous increase in microsomal UGT1A1 protein leading to stimulated bilirubin glucuronidation both in vivo and in microsomal vesicles. These results arise the possibility of the transcriptional induction and/or the mRNA stabilization by ethanol consumption, which can be caused by ethanol itself or the metabolic changes due to the treatment.
Asunto(s)
Bilirrubina/metabolismo , Depresores del Sistema Nervioso Central/farmacología , Etanol/farmacología , Glucuronosiltransferasa/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Animales , Citocromo P-450 CYP2E1/efectos de los fármacos , Citocromo P-450 CYP2E1/metabolismo , Inducción Enzimática/efectos de los fármacos , Glucuronosiltransferasa/metabolismo , Masculino , Microsomas Hepáticos/metabolismo , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Transcripción Genética/fisiologíaRESUMEN
LPS from bacteria can result in the development of sepsis syndrome and acute lung injury. Although acute exposure to endotoxin primes leukocytes for enhanced synthesis of leukotrienes (LT), little is known about the effect of chronic exposure. Therefore, we determined the effect of prolonged LPS treatment on 5-lipoxygenase (5-LO) metabolism of arachidonic acid in alveolar macrophages (AM) and in peripheral blood monocytes. Pretreatment of AM with LPS caused time- and dose-dependent suppression of LT synthetic capacity. LPS pretreatment failed to inhibit arachidonic acid (AA) release. The fact that LPS inhibited LT synthesis from endogenous AA more than from exogenous AA suggested an effect on 5-LO-activating protein (FLAP). In addition, an inhibitory effect of LPS treatment on AM 5-LO activity was suggested by cell-free 5-LO enzyme assay. No effect on the expression of either 5-LO or FLAP proteins was observed. New protein synthesis was necessary for LPS-induced reduction of 5-LO metabolism in AM, and immunoblotting demonstrated marked induction of NO synthase (NOS). Inhibition by LPS was reproduced by an NO donor and was abrogated by inhibitors of constitutive and inducible NOS. Compared with AM, peripheral blood monocytes exhibited no suppression by LPS of 5-LO metabolism and no induction of inducible NOS. We conclude that prolonged exposure to LPS impairs AM 5-LO metabolism by NO-mediated suppression of both 5-LO and FLAP function. Because LT contribute to antimicrobial defense, this down-regulation of 5-LO metabolism may contribute to the increased susceptibility to pneumonia in patients following sepsis.
Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Inhibidores Enzimáticos/farmacología , Lipopolisacáridos/farmacología , Inhibidores de la Lipooxigenasa , Macrófagos Alveolares/enzimología , Macrófagos Alveolares/inmunología , Óxido Nítrico/biosíntesis , Proteínas Activadoras de la 5-Lipooxigenasa , Animales , Araquidonato 5-Lipooxigenasa/biosíntesis , Ácido Araquidónico/metabolismo , Proteínas Portadoras/biosíntesis , Sistema Libre de Células/enzimología , Sistema Libre de Células/inmunología , Células Cultivadas , Ciclooxigenasa 2 , Relación Dosis-Respuesta Inmunológica , Activación Enzimática/inmunología , Represión Enzimática/inmunología , Femenino , Humanos , Isoenzimas/metabolismo , Isoenzimas/fisiología , Macrófagos Alveolares/metabolismo , Proteínas de la Membrana/biosíntesis , Monocitos/enzimología , Monocitos/inmunología , Monocitos/metabolismo , Óxido Nítrico/fisiología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Prostaglandina-Endoperóxido Sintasas/fisiología , Biosíntesis de Proteínas , Proteínas/fisiología , Ratas , Ratas Wistar , Factores de TiempoRESUMEN
To characterize the role of GM-CSF in pulmonary fibrosis, we have studied bleomycin-induced fibrosis in wild-type mice vs mice with a targeted deletion of the GM-CSF gene (GM-CSF-/- mice). Without GM-CSF, pulmonary fibrosis was worse both histologically and quantitatively. These changes were not related to enhanced recruitment of inflammatory cells because wild-type and GM-CSF-/- mice recruited equivalent numbers of cells to the lung following bleomycin. Interestingly, recruitment of eosinophils was absent in GM-CSF-/- mice. We investigated whether the enhanced fibrotic response in GM-CSF-/- animals was due to a deficiency in an endogenous down-regulator of fibrogenesis. Analysis of whole lung homogenates from saline- or bleomycin-treated mice revealed that GM-CSF-/- animals had reduced levels of PGE2. Additionally, alveolar macrophages were harvested from wild-type and GM-CSF-/- mice that had been exposed to bleomycin. Although bleomycin treatment impaired the ability of alveolar macrophages from wild-type mice to synthesize PGE2, alveolar macrophages from GM-CSF-/- mice exhibited a significantly greater defect in PGE2 synthesis than did wild-type cells. Exogenous addition of GM-CSF to alveolar macrophages reversed the PGE2 synthesis defect in vitro. Administration of the PG synthesis inhibitor, indomethacin, to wild-type mice during the fibrogenic phase postbleomycin worsened the severity of fibrosis, implying a causal role for PGE2 deficiency in the evolution of the fibrotic lesion. These data demonstrate that GM-CSF deficiency results in enhanced fibrogenesis in bleomycin-induced pulmonary fibrosis and indicate that one mechanism for this effect is impaired production of the potent antifibrotic eicosanoid, PGE2.
Asunto(s)
Bleomicina/farmacología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/fisiología , Prostaglandinas/fisiología , Fibrosis Pulmonar/etiología , Fibrosis Pulmonar/metabolismo , Animales , Bleomicina/administración & dosificación , División Celular/genética , Dinoprostona/antagonistas & inhibidores , Dinoprostona/biosíntesis , Dinoprostona/deficiencia , Esquema de Medicación , Factor Estimulante de Colonias de Granulocitos y Macrófagos/administración & dosificación , Factor Estimulante de Colonias de Granulocitos y Macrófagos/deficiencia , Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Indometacina/administración & dosificación , Inyecciones Intramusculares , Inyecciones Intraperitoneales , Intubación Intratraqueal , Cinética , Recuento de Leucocitos , Leucotrieno C4/biosíntesis , Leucotrieno C4/deficiencia , Metabolismo de los Lípidos , Lípidos/biosíntesis , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Monocitos/patología , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/genética , Cloruro de Sodio/administración & dosificaciónRESUMEN
Eleven species of Neotropical migrant passerines collected in Illinois (USA) during May 1996, were analyzed for the presence of organochlorine (OC) pesticides. At least one of five OC pesticide residues was detected in 66 of 72 birds, representing all species examined. The contaminants most frequently detected were p,p'-DDE, dieldrin and heptachlor epoxide, all of which were present in the 10-30 ng/g range. Insectivores had significantly higher levels of these compounds than did non-insectivores, while there was no significant main effect of winter habitat (forest and scrub). Future research on OC pesticide contamination in resident New World passerines may allow more accurate predictions regarding the sources of contamination in Neotropical migrants.
Asunto(s)
Hidrocarburos Clorados , Insecticidas/análisis , Pájaros Cantores , Animales , Dieta , Ambiente , Movimiento , Estaciones del Año , Distribución TisularRESUMEN
The Missouri Department of Conservation detected high organochlorine levels in tissues of fish from the Mississippi River south of Saint Louis. Chlordane, which is both a carcinogen and an endocrine disrupter, reached 2960 micrograms/kg in fillets of shovelnose sturgeon, Scaphirhynchus platyorynchus, and 1926 micrograms/kg in their roe, wet weight basis. Polychlorinated biphenyls (PCBs) and p,p'-dichlorodiphenyldichloroethylene (DDE) in roe have reached 5810 and 780 micrograms/kg, respectively. The purpose of this study was to determine if endocrine disrupters and carcinogens are a potential cause of the significantly diminished reproduction capacity and population declines in the endangered pallid sturgeon, Scaphirhynchus albus. Twenty-four surrogate shovelnose sturgeons were sampled north of Saint Louis where contaminant levels were lower compared with 17 sampled south of Saint Louis where contaminant levels were high. Liver and gonad tissues were formalin-fixed, histologically processed and examined. Neoplasms were not found. The principal finding was that the testes of two of the seven downstream male fish contained ovigerous lamellae, in addition to mature sperm. Since sturgeons are gonochoristic and intersexes are rare and unusual, the occurrence of intersex in 29% of the male Mississippi River shovelnose sturgeon examined from a population contaminated with chlordane and other chemicals raise concern for human health, species biodiversity and preservation of waterway quality. These findings, however, need to be corroborated by expanded studies with a higher sample size.
Asunto(s)
Carcinógenos/toxicidad , Diclorodifenil Dicloroetileno/toxicidad , Peces/crecimiento & desarrollo , Insecticidas/toxicidad , Bifenilos Policlorados/toxicidad , Reproducción/efectos de los fármacos , Contaminantes Químicos del Agua/toxicidad , Animales , Carcinógenos/análisis , Diclorodifenil Dicloroetileno/análisis , Femenino , Agua Dulce , Insecticidas/análisis , Hígado/química , Hígado/efectos de los fármacos , Masculino , Missouri , Ovario/química , Ovario/efectos de los fármacos , Bifenilos Policlorados/análisis , Testículo/química , Testículo/efectos de los fármacos , Contaminantes Químicos del Agua/análisisRESUMEN
Alveolar macrophages (AM) are the primary resident effector cells in the alveolus. Leukotrienes (LT) are secreted by AM in their role as defender of the lung. 5-Lipoxygenase (5-LO) catalyzes the synthesis of LT in association with 5-LO-activating protein, termed "FLAP." AM demonstrate increased 5-LO metabolism compared to peripheral blood monocytes (PBM). Activated lymphocytes release mediators which upregulate 5-LO metabolism in PBM. The lymphocyte population of the lung consists predominantly of CD4+ helper constitutively "activated" T cells. We hypothesized that mediators released by pulmonary CD4+ T cells may upregulate and maintain of 5-LO metabolism in PBM as they enter the alveolar space and differentiate into AM. 5-LO metabolism in AM from CD4-depleted mice demonstrated reduced LT synthesis (LTC4: 66.9 +/- 8%; LTB4 61.4 +/- 6.2% control). The decrease in 5-LO metabolism was associated with reduced FLAP (30.1 +/- 14.5% of control) and 5-LO expression (49 +/- 13.7% of control). This defect in AM 5-LO metabolism in CD4-depleted mice was further associated with reduced LTC4 levels in bronchoalveolar lavage (BAL) fluid. In summary, factors secreted constitutively by lung lymphocytes, in particular CD4 cells, contribute to the increased 5-LO metabolism in AM.
Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Linfocitos T CD4-Positivos/fisiología , Macrófagos Alveolares/enzimología , Fagocitos/enzimología , Proteínas Activadoras de la 5-Lipooxigenasa , Animales , Ácido Araquidónico/metabolismo , Líquido del Lavado Bronquioalveolar/química , Linfocitos T CD4-Positivos/inmunología , Proteínas Portadoras/metabolismo , Comunicación Celular , Leucotrieno B4/biosíntesis , Leucotrieno C4/biosíntesis , Depleción Linfocítica , Macrófagos Alveolares/metabolismo , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos CBA , Fagocitos/metabolismoRESUMEN
Leukotrienes (LT) are mediators derived from the 5-lipoxygenase (5-LO) pathway, which play a role in host defense, and are synthesized by both monocytes (peripheral blood monocyte [PBM]) and neutrophils (PMN). Because 5-LO metabolism is reduced in alveolar macrophages and PMN from acquired immunodeficiency syndrome (AIDS) subjects, we investigated the synthesis of LT by PBM and PMN from these subjects. There was a reduction (74.2% +/- 8.8% of control) in LT synthesis in PBM from human immunodeficiency virus (HIV)-infected compared with normal subjects. Expression of 5-LO (51.2% +/- 8.8% of control), and 5-LO activating protein (FLAP) (48.5% +/- 8.0% of control) was reduced in parallel. We hypothesized that this reduction in LT synthetic capacity in PBM and PMN was due to reduced cytokine production by CD4 T cells, such as granulocyte-macrophage colony-stimulating factor (GM-CSF). We treated 10 AIDS subjects with GM-CSF for 5 days. PBM 5-LO metabolism ex vivo was selectively increased after GM-CSF therapy and was associated with increased 5-LO and FLAP expression. PMN leukotriene B(4) (LTB(4)) synthesis was also augmented and associated with increased 5-LO, FLAP, and cytosolic phospholipase A(2) expression. In conclusion, as previously demonstrated for PMN, PBM from AIDS subjects also demonstrate reduced 5-LO metabolism. GM-CSF therapy reversed this defect in both PBM and PMN. In view of the role of LT in antimicrobial function, cytokine administration in AIDS may play a role as adjunct therapy for infections.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Araquidonato 5-Lipooxigenasa/sangre , Factor Estimulante de Colonias de Granulocitos y Macrófagos/administración & dosificación , VIH-1 , Monocitos/metabolismo , Neutrófilos/metabolismo , Síndrome de Inmunodeficiencia Adquirida/sangre , Síndrome de Inmunodeficiencia Adquirida/enzimología , Humanos , Inyecciones Subcutáneas , Estudios Prospectivos , Regulación hacia ArribaRESUMEN
The pathogenesis of HIV-1 infection is influenced by the immunoregulatory responses of the host. Macrophages present in the lymphoid tissue are susceptible to infection with HIV-1, but are relatively resistant to its cytopathic effects and serve as a reservoir for the virus during the course of disease. Previous investigators have demonstrated that increased serum levels of TNF-alpha contribute to the clinical symptoms of AIDS and that TNF-alpha stimulates the production of HIV-1 in chronically infected lymphocytic and monocytic cell lines by increasing HIV-1 gene expression. Although previous studies have suggested that TNF-alpha may increase HIV-1 infection of primary human mononuclear cells, some recent studies have indicated that TNF-alpha suppresses HIV-1 infection of macrophages. We now demonstrate that TNF-alpha suppresses HIV-1 replication in freshly infected peripheral blood monocytes (PBM) and alveolar macrophages (AM) in a dose-dependent manner. As TNF-alpha has been shown to increase the production of C-C chemokine receptor (CCR5)-binding chemokines under certain circumstances, we hypothesized that TNF-alpha inhibits HIV-1 replication by increasing the expression of these HIV-suppressive factors. We now show that TNF-alpha treatment of PBM and AM increases the production of the C-C chemokine, RANTES. Immunodepletion of RANTES alone or in combination with macrophage inflammatory protein-1alpha and -1beta block the ability of TNF-alpha to suppress viral replication in PBM and AM. In addition, we found that TNF-alpha treatment reduces CCR5 expression on PBM and AM. These findings suggest that TNF-alpha plays a significant role in inhibiting monocytotropic strains of HIV-1 by two distinct, but complementary, mechanisms.
Asunto(s)
Antivirales/fisiología , Antagonistas de los Receptores CCR5 , Quimiocina CCL5/biosíntesis , VIH-1/inmunología , Macrófagos Alveolares/inmunología , Monocitos/inmunología , Factor de Necrosis Tumoral alfa/fisiología , Replicación Viral/inmunología , Adyuvantes Inmunológicos/fisiología , Membrana Celular/inmunología , Membrana Celular/metabolismo , Quimiocina CCL5/inmunología , Quimiocinas CC/biosíntesis , Regulación hacia Abajo/inmunología , VIH-1/metabolismo , Humanos , Inmunosupresores/antagonistas & inhibidores , Inmunosupresores/farmacología , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/virología , Monocitos/metabolismo , Monocitos/virología , Receptores CCR5/biosíntesis , Factor de Necrosis Tumoral alfa/antagonistas & inhibidoresRESUMEN
The co-ordinated induction of several hepatic drug-metabolizing enzymes is a common feature in the regulation of drug biotransformation under normal and pathological conditions. In the present study the activity and expression of bilirubin UDP-glucuronosyltransferase (UGT1A1) were investigated in livers of BioBreeding/Worcester diabetic, fasted and acetone-treated rats. Bilirubin glucuronidation was stimulated by all three treatments; this was correlated with an increase in the UGT1A1 protein concentration in hepatic microsomes. Transcriptional induction of UGT1A1 was also observed in diabetes and starvation but not with acetone treatment, which apparently caused translational stabilization of the enzyme protein. The hormonal/metabolic alterations in diabetes and starvation might be a model for postnatal development. The sudden interruption of maternal glucose supply signals the enhanced expression of UGT1A1, giving a novel explanation for the physiological induction of bilirubin glucuronidation in newborn infants.
Asunto(s)
Acetona/farmacología , Diabetes Mellitus Tipo 1/enzimología , Glucuronosiltransferasa/biosíntesis , Inanición/enzimología , Animales , Electroforesis en Gel de Poliacrilamida , Inducción Enzimática , Glucuronosiltransferasa/genética , Masculino , Microsomas Hepáticos/enzimología , Ratas , Ratas Endogámicas BB , Ratas WistarRESUMEN
The enzyme 5-lipoxygenase (5-LO) catalyses the synthesis of leukotrienes (LT), which are important in phagocytosis and killing of microorganisms. The alveolar macrophage (AM), the primary resident defender of the alveolar space, has a greater capacity for LT synthesis than its precursor, the peripheral blood monocyte (PBM). This study investigated whether the alveolar lining fluid (ALF) upregulates LT synthetic capacity in mononuclear phagocytes. Rat AM, peritoneal macrophages (PM) and ALF were obtained by lavage from pathogen-free animals. Human PBM were isolated from normal subjects. 5-LO metabolism and expression were measured with and without ALF. Rat ALF increased 5-LO metabolism (136.4+/-15.1% of control) in cultured PBM. This was associated with increased 5-LO activating protein (FLAP) (357+/-29.5 %), and 5-LO expression (188+/-31.3%). Culture of AM for 3 days resulted in a greater decrement in LTB4 synthesis (LTB4 15.4+/-6.9% of day 1) than in PM (54.7+/-8.3% of day 1), suggesting a greater dependence of AM 5-LO metabolism on ALF. 5-LO and FLAP expression decreased to a greater degree in AM than PM in culture. Furthermore, AM cultured with ALF maintained their LT synthetic capacity, FLAP and 5-LO expression compared with control cells cultured in medium alone. In conclusion, alveolar lining fluid increased 5-lipoxygenase metabolism in peripheral blood monocytes and maintained it in cultured alveolar macrophages, by a mechanism of increased 5-lipoxygenase and 5-lipoxygenase activating protein expression. This may boost host defence capabilities.
Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Líquidos Corporales/fisiología , Macrófagos Alveolares/enzimología , Macrófagos Peritoneales/enzimología , Alveolos Pulmonares , Proteínas Activadoras de la 5-Lipooxigenasa , Animales , Ácido Araquidónico/metabolismo , Western Blotting , Líquido del Lavado Bronquioalveolar , Proteínas Portadoras/metabolismo , Células Cultivadas , Femenino , Humanos , Técnicas para Inmunoenzimas , Leucotrieno B4/metabolismo , Macrófagos Alveolares/metabolismo , Proteínas de la Membrana/metabolismo , Monocitos/metabolismo , Ratas , Ratas WistarRESUMEN
The proinflammatory leukotrienes (LT) play important roles in host defense and disease states. However, no endogenous mechanisms to downregulate 5-lipoxygenase (5-LO), the enzyme catalyzing LT synthesis, have been described. We observed that the cytosolic fraction of rat alveolar macrophages (AMs) and peritoneal macrophages (PMs), and of peripheral blood monocytes (PBMs) contain substantial amounts of 5-LO protein, but little detectable 5-LO activity. We therefore examined these mononuclear phagocyte (MNP) cytosolic fractions for inhibitory activity against 5-LO. MNP cytosol dose-dependently reduced the 5-LO activity in neutrophil (PMN) cytosol and AM membrane. Furthermore, MNP cytosol dose-dependently prolonged the lag phase of soybean lipoxygenase (LO) without affecting the rate of product formation. This effect was overcome by subsequent addition of 13(S)-hydroperoxy-9-cis-11-trans-octadecadienoic acid (13-HpOD), suggesting that the active factor scavenges hydroperoxides. Inactivation by boiling and roteinase K suggest that is a protein. We speculate that this cytosolic factor(s) may serve as an endogenous means for the down-regulation of 5-LO in macrophages.
Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Citosol/química , Homeostasis , Inhibidores de la Lipooxigenasa/análisis , Fagocitos/enzimología , Animales , Células Cultivadas , Citosol/enzimología , Peróxido de Hidrógeno/farmacología , Immunoblotting , Macrófagos Alveolares/enzimología , Macrófagos Alveolares/ultraestructura , Macrófagos Peritoneales/enzimología , Macrófagos Peritoneales/ultraestructura , Monocitos/enzimología , Monocitos/ultraestructura , Neutrófilos/enzimología , Fagocitos/ultraestructura , Ratas , Glycine max/enzimologíaRESUMEN
Neutrophil (PMN) dysfunction occurs in HIV infection. Leukotrienes (LT) are mediators derived from the 5-lipoxygenase (5-LO) pathway that play a role in host defense and are synthesized by PMN. We investigated the synthesis of LT by PMN from HIV-infected subjects. There was a reduction (4.0+/-1.3% of control) in LT synthesis in PMN from HIV-infected compared with normal subjects. This was associated with reduced expression of 5-LO-activating protein (31.2+/-9.6% of normal), but not of 5-LO itself. Since HIV does not directly infect PMN, we considered that these effects were due to reduced release of cytokines, such as granulocyte colony-stimulating factor (G-CSF). We examined the effect of G-CSF treatment (300 microgram daily for 5 d) on eight HIV-infected subjects. PMN were studied in vitro before therapy (day 1) and on days 4 and 7. LTB4 synthesis was increased on day 4 of G-CSF treatment, and returned toward day 1 levels on day 7. 5-LO and 5-LO-activating protein expression were increased in parallel. As a functional correlate to this increase in PMN LT synthesis by G-CSF, we examined the effects on killing of Cryptococcus neoformans. Anticryptococcal activity of PMN from HIV-infected subjects was less than that of PMN from normal subjects. G-CSF treatment improved fungistatic activity of PMN. This increase in antifungal activity was attenuated by in vitro treatment with the LT synthesis inhibitor, MK-886. In conclusion, PMN from HIV-infected subjects demonstrate reduced 5-LO metabolism and antifungal activity in vitro, which was reversed by in vivo G-CSF therapy.